Free Market Health

Payers need partners who evolve with them. Pharmacies need equitable access to the right patient opportunities. Patients need an orchestrated process that works for them. If you’re a forward-thinking payer heading to #AMCP2025 and tired of the one-size-fits all approach to specialty drug management, let’s talk. Visit our team at booth 424 or schedule time with us to explore how we can optimize your specialty pharmacy program. Schedule time here: https://lnkd.in/eDc4GgkA

Abarca Health knows how to host an event! Our President & COO Mark Conklin took the stage at #AbarcaForward2025 for a lightning round on the specialty drug marketplace model, joining an incredible group of industry leaders driving real change. His message was clear: legacy models are rigid and opaque, and the future of specialty pharmacy must be transparent and patient centered. Thanks to Abarca for letting us be a part of such an important conversation. Bringing folks together under one roof to tackle the biggest challenges in pharmacy management is how we move the industry forward.?

We're excited to take the stage alongside some talented industry leaders at #AbarcaForward2025 next week to get real about the new way of managing specialty drug programs. If you're there, join us Tuesday afternoon for a lightning talk on marketplace models and join the conversation by bringing your most pressing questions to the session.

We’re excited to share that our own Brian Sidone has been appointed SVP, Pharmacy Strategy at FMH! Brian will use his deep expertise to spearhead a team laser-focused on enhancing our execution of custom pharmacy strategies.?? ?? “The drug channel is evolving at a rapid pace, and payers need a partner who can design, deliver, and manage pharmacy programs that drive meaningful results. At FMH, we unlock the value that specialty pharmacies create—ensuring their expertise is recognized and leveraged by payers to meet their goals. In this new role, I’m excited to lead a dedicated team focused on building strategic programs that align pharmacy value with payer needs, with the ultimate goal of creating a system that works for everyone—one that ultimately keeps patient care at the center,” says Brian.? ? Join us in congratulating Brian!

What a week to remember at FMH HQ! From reflecting on 2024’s milestones to aligning on 2025 strategy, our team brought energy to two days of learning for our FMH All Team?Meeting last week. We wrapped it up with our inaugural FMH Gala on Thursday—a night to celebrate our people and our achievements. To our team: thank you for continuing to show up. 2025 is set to be a remarkable year!

Our own Timothy Mizak, PharmD, MS, MBA, Director, Clinical Product Strategy, has been selected to join the Pharmacy Quality Alliance (PQA) Measure Update Panel, a group dedicated to ensuring PQA measures align with current clinical guidelines and remain viable in the marketplace.?? ? Reflecting on this opportunity, Tim shared: "I’ve been passionate about leveraging data and clinical expertise to improve medication management and drive quality in pharmacy care throughout my career. At FMH, we’re deeply committed to advancing pharmacy quality, particularly in the specialty drug space, and I'm excited to contribute to this important work alongside a dedicated group of professionals to enhance clarity, consistency, and patient outcomes across the healthcare landscape.”? ? Congratulations, Tim, on this well-deserved appointment!

In case you missed it, our Founder and CEO Joe Cardosi participated in an insightful panel discussion at Empower 2024 alongside John Scott of Agios Pharmaceuticals and Ernie Shopes of Inovalon.?? ?? The focus? Collaboration between pharmacy and pharma to advance patient access. Joe shares how FMH orchestrates stakeholders across the specialty pharmacy ecosystem-unbiasedly and efficiently-to ensure patients receive high-quality care when they need it most.?? ?? The main takeaway? Keep the patient at the center of every decision while embracing innovation to reduce inefficiencies and improve outcomes.? ?? Watch the full panel discussion here: https://lnkd.in/gmp_iMsf?

2024 marked a truly transformational year for Free Market Health. We were selected as a best place to work by Modern Healthcare and Pittsburgh Business Times, reflecting our commitment to fostering a collaborative workplace. We grew our employee base by 45%, strengthening our ability to deliver impactful solutions. We experienced significant business growth, increasing specialty referral volume by 165%. We continued to prioritize our client’s data, completing the SOC Type 2 Audit for the third consecutive year. We amplified our industry presence, connecting with peers and thought leaders to shape the future of specialty pharmacy. We gave back to our community, supporting multiple philanthropic and industry organizations. We’re incredibly proud of our team’s accomplishments this year. As we look ahead to 2025, we remain focused on our most important goal: never letting the process fail the patient.

Today, we’re excited to announce an organizational evolution to align with our rapid growth and future in the specialty pharmacy industry. With an increasing demand for a tailored, alternative specialty pharmacy model, this new structure will allow us to stay committed to offering an agile and adaptable team that’s well positioned for this next chapter of growth.? ? We look forward to continued momentum, working together with our talented team and valued clients to shape the future of specialty pharmacy. Read more here: https://lnkd.in/gh_rep4d

Heading to AMCP Nexus today? Visit us at booth 306 to discuss your specialty drug program goals and discover how our highly configurable care-driven marketplace platform can help you achieve them. You can also find Justine Wiebusch, Pharm.D., MBA, Jennifer Polzin, PharmD, FCSHP, BCACP, CPHQ, Jeremy Urbas, and Scott Cuppy at the event to learn how Free Market Health can take your specialty drug program to the next level. #AMCPNexus